Original articleAbsence of KHDC3L mutations in Chinese patients with recurrent and sporadic hydatidiform moles
Section snippets
Materials and methods
In this study, we investigated the presence of KHDC3L mutations in a total of 101 unrelated Chinese patients. A questionnaire recapitulating the medical and family histories was completed for every patient. DNA was isolated from whole blood cells using a Flexigene DNA kit (Qiagen, Valencia, CA). Patients were gathered from various clinics in the province of Zhejiang. Histopathology slides from all HM tissues were reviewed by the pathologist of the Women's Hospital at the Zhejiang University
Results
Among these 101 patients, NLRP7 sequencing had been performed only for the 15 patients with RHMs, and no mutations were found. KHDC3L sequences were compared with reference sequence NM_001017361.2 and annotated. This analysis did not reveal any mutation. In the three analyzed categories of patients, only two NSVs in KHDC3L that are reported in public databases were observed, c.289G>C leading to p.E97Q and c.602C>G leading to p.A201G. These two NSVs were found at similar frequencies in our 101
Discussion
The lack of KHDC3L mutations in the 15 analyzed patients with recurrent moles could be because these patients did not have high numbers of RHMs and reproductive losses, with an average of 2.5, compared with previously reported patients with KHDC3L mutations, who had on average 6.3 pregnancies 20, 21. This argument may also explain the lower frequency of NLRP7 mutations found in an overlapping cohort of Chinese patients with at least two HMs, 48%, relative to the frequencies of NLRP7 mutations
Acknowledgments
We thank the patients, their families, and control participants for their cooperation.
This work was supported by the National Natural Science Foundation of China (30973172); the National Natural Science Foundation of China (81261120569); Major Science and Technology Projects of Science and technology Department of Zhejiang Province (2009C14012); and the Canadian Institute of Health Research (CCI-125687).
References (21)
Epidemiology of gestational trophoblastic disease
Am J Obstet Gynecol
(1984)- et al.
Heterogeneity in recurrent complete hydatidiform mole: presentation of two new Turkish families with different genetic characteristics
Placenta
(2010) - et al.
The spectrum of NLRP7 mutations in French patients with recurrent hydatidiform mole
Eur J Obstet Gynecol Reprod Biol
(2011) - et al.
Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte
Am J Hum Genet
(2011) - et al.
Epidemiology of hydatidiform mole and choriocarcinoma
Epidemiol Rev
(1984) - et al.
Revisiting the pathology of hydatidiform moles: New findings and the mysteries that remain
- et al.
Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans
Nat Genet
(2006) - et al.
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region
J Med Genet
(2009) - et al.
A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation
Clin Genet
(2009) - et al.
Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations
Hum Mutat
(2007)